2024年世界卫生组织慢性乙型肝炎预防与管理指南更新:主要变化及对下一版主要肝病学会临床实践指南的潜在影响
本文分析2024年3月世界卫生组织(WHO)修订的慢性乙型肝炎预防与管理指南的制定过程和新推荐,指出简化诊疗和扩大治疗标准是本次修订核心,并探讨其对欧洲、美国、亚洲肝病学会下一版乙肝指南可能的一致与争议领域。
要点
- WHO 2024年3月发布修订版慢性乙型肝炎预防与管理指南,核心为简化诊疗和扩大治疗标准。
- 全球消除乙肝病毒进展缓慢,多数国家远未达到WHO设定的消除目标。
- WHO更新指南对EASL、AASLD和APASL下一版乙肝推荐的影响尚不确定。
核心结论
- 简化诊疗和扩大治疗标准是WHO 2024年修订版慢性乙型肝炎指南的核心。
- WHO更新指南是否及如何影响国际肝病学会(EASL、AASLD和APASL)下一版乙肝推荐仍不确定。
- 欧洲、美洲和亚洲区域包含多个高乙肝地方流行性的低、中、中高收入国家及脆弱人群,应受益于简化的临床算法。
研究设计与样本
- 本文为对WHO指南制定过程及其新推荐的分析,旨在识别与下一版肝病学会乙肝指南预期的一致领域和争议点。
主要发现
- 全球消除乙肝病毒进展缓慢,多数国家远未达到WHO设定的消除目标。
- 慢性乙型肝炎负担主要由资源有限国家承担,其中仅少数乙肝病毒感染者被诊断和治疗,国际指南在现实中难以适用。
- 2024年3月WHO发布修订版慢性乙型肝炎预防与管理指南。
- 简化诊疗和扩大治疗标准是本次修订的核心。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Progress towards global elimination of hepatitis B virus (HBV) has been slow and most countries are far from reaching the elimination targets set out by the World Health Organization (WHO). The burden of chronic hepatitis B is mainly borne by resource-limited countries where only a minority of people living with HBV are diagnosed and treated, and international guidelines are hardly applicable in real-life. In March 2024, the WHO released its revised guidelines for the prevention and management of chronic hepatitis B. Simplification of care and expansion of treatment criteria represent the core of this revision. Whether and how these updated WHO guidelines will influence the next hepatitis B recommendations from the international liver societies (EASL, AASLD and APASL) remain uncertain. Yet, the European, American and Asian regions encompass multiple low, middle and intermediate-income countries with high HBV endemicity and vulnerable populations that should benefit from simplified clinical algorithms. Here, from an analysis of the WHO guideline development process and its new recommendations, we aimed to identify the anticipated areas of agreement and controversies with the next liver society hepatitis B guidelines, which will have to balance clinical risks and benefits for patients.
引用
- Wong GL, Lemoine M. The 2024 updated WHO guidelines for the prevention and management of chronic hepatitis B: Main changes and potential implications for the next major liver society clinical practice guidelines. J Hepatol. 2024. PMID: 39647534. doi:10.1016/j.jhep.2024.12.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。